These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3327106)

  • 41. Measurement of cellular and soluble immunologic changes in vivo in human leprosy lesions.
    Scollard DM; Theetranont C; Suriyanon V; Bhoopat L; Rangdaeng S; Thamprasert K; Smith T
    Acta Leprol; 1989; 7 Suppl 1():149-52. PubMed ID: 2503974
    [No Abstract]   [Full Text] [Related]  

  • 42. [Tuberculoid leprosy treated with rifampicin].
    Guilaine J; Stérin D; Després E; Lesobre R
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):749-50. PubMed ID: 5384187
    [No Abstract]   [Full Text] [Related]  

  • 43. A preliminary clinical trial of rifampicin in leprosy.
    Bhide MB; Desai AC; Ganapati R
    Lepr India; 1976 Oct; 48(4 Suppl):781-3. PubMed ID: 1026816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Sequential activation of cellular and humoral immunity in leprosy: considerations based on recent findings].
    Rojas-Espinosa O; Jiménez-Zamudio L; Arce-Paredes P
    Rev Latinoam Microbiol; 1994; 36(3):213-9. PubMed ID: 7709098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of macrophage inhibitory factor by patients with leprosy.
    Katz SI; DeBetz BH; Zaias N
    Arch Dermatol; 1971 Apr; 103(4):358-61. PubMed ID: 5091865
    [No Abstract]   [Full Text] [Related]  

  • 47. Leprosy. XI. Evaluation of thymus-derived lymphocytes by an antihuman T-lymphocyte antiserum.
    Lim SD; Touraine JL; Storkan MA; Choe YS; Good RA
    Int J Lepr Other Mycobact Dis; 1974; 42(3):260-5. PubMed ID: 4549214
    [No Abstract]   [Full Text] [Related]  

  • 48. [Identification of T and B lymphocytes from human peripheral blood by the rosette techniques (author's transl)].
    Mazuran R; Silobrcić V
    Lijec Vjesn; 1980 Feb; 102(2):98-104. PubMed ID: 6967549
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cellular immunity in idiopathic nephrotic syndrome with minimal glomerular lesions and focal and segmental hyalinosis in children].
    Batellier H; Dechelette E; Bensa JC; Bost M
    Arch Fr Pediatr; 1983 Mar; 40(3):149-55. PubMed ID: 6603829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy.
    Singh PK; Ratna ; Jain PK; Mital VP
    Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of leprosy sera and foetal calf serum (FCS) on the T cell number of peripheral blood of leprosy patients.
    Patil SA; Ramu G; Dwivedi PD; Sinha S; Ghei SK; Sengupta U
    Indian J Lepr; 1984; 56(4):784-91. PubMed ID: 6335891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapeutic effect of rifampicin (RFP) on leprosy. IV. Serological examination (author's transl)].
    Abe M; Minagawa F; Yoshino Y
    Repura; 1974; 43(1):45-51. PubMed ID: 4479676
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes in rosette count under the effect of tuberculin antigen (in vitro study of tuberculin type hypersensitivity)].
    Katona Z; Nádasdy T
    Orv Hetil; 1981 Apr; 122(16):943-5. PubMed ID: 6973120
    [No Abstract]   [Full Text] [Related]  

  • 54. Cellular immunity in leprosy.
    Baliña LM; Fliess EL; Cardama JE; Gatti JC; Bachmann A
    Int J Dermatol; 1974; 13(5):300-2. PubMed ID: 4425083
    [No Abstract]   [Full Text] [Related]  

  • 55. Investigation of lymphocyte subpopulations and hypersensitivity skin tests during the menstrual cycle and pregnancy.
    Agarwal S; Shukla HS; Verma M; Gupta SC; Mukherjee K
    Ann Chir Gynaecol; 1982; 71(2):117-21. PubMed ID: 6979972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [General principles of specific defense in postnatal infections].
    Stemberger H; Wiedermann G
    Wien Med Wochenschr; 1972 Apr; 122(15):210-6. PubMed ID: 4603557
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current concepts of the growth mechanisms of the immune response].
    Voĭtenok NN
    Ter Arkh; 1980; 52(9):132-40. PubMed ID: 6449091
    [No Abstract]   [Full Text] [Related]  

  • 58. Regulation of cell-mediated immunity in lepromatous leprosy.
    Kaplan G; Cohn ZA
    Lepr Rev; 1986 Dec; 57 Suppl 2():199-202. PubMed ID: 3106737
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of cellular immunity in diabetic uraemics by cutaneous response to recall antigens and 2:4 dinitrochlorobenzene and T-cell rosette formation.
    Kuamr S; Singh RG; Gupta RM
    Indian J Pathol Microbiol; 1993 Apr; 36(2):129-32. PubMed ID: 8276475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional role for Ig free light chains in immediate and delayed hypersensitivity responses.
    Redegeld FA; Van Der Heijden MW; Kool M; Kraneveld AD; Nijkamp FP
    Inflamm Res; 2004 Mar; 53 Suppl 1():S6-8. PubMed ID: 15054593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.